Top Sell
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Organovo Holdings Inc. | 0 | 9 | 0 | 1 | €0.50 | - | - |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.10 | - | - |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.19 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Minerva Neurosciences Inc. | 0 | 10 | 0 | 1 | €2.32 | - | - |
| Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | €0.83 | €4.99 | 501.494% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.00 | €50.00 | 38.889% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 99.377% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.08 | €50.00 | 4521.072% |
| Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Trevena Inc. | 2 | 23 | 0 | 2 | €0.15 | €6.48 | 4136.601% |
| Glycomimetics Inc. | 3 | 7 | 0 | 4 | €0.14 | €9.13 | 6424.714% |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.16 | €7.31 | 131.049% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €49.45 | - | - |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.68 | €5.49 | 711.709% |
| Syros Pharmaceuticals Inc. | 9 | 1 | 2 | 0 | €1.41 | €12.01 | 751.454% |
| Cara Therapeutics Inc. | 10 | 7 | 0 | 3 | €0.29 | €4.61 | 1468.593% |
| Intellia Therapeutics Inc | 15 | 1 | 2 | 0 | €18.85 | €60.53 | 221.189% |